Target intelligence / Profile preview

Nucleophosmin 1 pseudogene 39 (NPM1P39)

Target
NPM1P39
Molecular classification
Pseudogene, Processed pseudogene (likely: processed, as most gene symbol pseudogenes ending in "P" are processed rather than unprocessed—i.e., formed via reverse transcription and lacking introns)
01

Overview

Nucleophosmin 1 pseudogene 39 (NPM1P39) is a genomic DNA sequence related to the NPM1 gene but has lost the ability to code for a functional protein, primarily due to accumulated mutations and lack of necessary regulatory regions[2][6]. Pseudogenes such as NPM1P39 are classified by their origin (processed or unprocessed), and while some pseudogenes have been shown to modulate gene expression or participate in gene regulatory networks, NPM1P39 itself does not possess documented functional, regulatory, or disease associations distinct from its parent gene, nucleophosmin 1 (NPM1)[2][6][8]. Its relevance is mainly genomic, with potential—but unproven—roles in gene regulation by mechanisms such as miRNA sponging or gene conversion. It is not a protein, enzyme, transporter, or receptor, nor is it a known drug target.

Other names
nucleophosmin (nucleolar phosphoprotein B23, numatrin) pseudogenenucleophosmin 1 (nucleolar phosphoprotein B23, numatrin) pseudogene 39NPM1P39
02

Biological functions

Possible regulation of parental NPM1 gene expression via competing endogenous RNA effects, gene conversion, or RNA-mediated regulation. These are general pseudogene roles; no specific function attributed to NPM1P39 is reportedOther
03

Disease associations

Other (general pseudogene involvement in disease via recombination or gene conversion, but no direct link for NPM1P39)

Beyond the preview

Go deeper on Nucleophosmin 1 pseudogene 39 (NPM1P39).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleophosmin 1 pseudogene 39 (NPM1P39).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call